top of page

Enabling our partners improve patients’ lives

About Us

At Eirgen Pharma, we simplify your path to market with full turnkey CDMO services, specializing in the development, manufacture, and packaging of high-potency Oral Solid Dose (OSD) pharmaceuticals for human and animal health. As a trusted pharmaceutical contract partner, we offer GMP-compliant solutions that ensure regulatory compliance and quality assurance across every stage of the drug development lifecycle. 

Our expertise spans oncology drug development, specialty generics, and veterinary pharmaceuticals, ensuring your product is handled with precision and care. 

With a proven track record in high-volume manufacturing, we help you navigate complex regulatory landscapes whilst accelerating your time-to-market. Whether you're seeking EU and FDA-approved facilities, serialization-ready packaging, or high-containment manufacturing, we provide scalable, cost-effective solutions to meet the growing demands of the global pharmaceutical market. 
 

Our Mission

To provide innovative development, manufacturing and packaging solutions to our partners.

Our Story

Founded in 2005 by Patsy Carney and Tom Brennan, Eirgen Pharma has grown to become a global leader in the development and manufacturing of high-quality pharmaceutical formulations, specializing in film-coated tablets, softgel capsules, and powder or liquid-filled hard-shell capsules. 

Our focus on producing complex and high-potency medicines, particularly oncology therapies, specialty pharmaceuticals, and niche generics, established Eirgen Pharma as a trusted CDMO (Contract Development and Manufacturing Organization) and CMO (Contract Manufacturing Organization) for some of the world's leading pharmaceutical companies. 

In 2015, Eirgen Pharma joined the OPKO Health family, enabling us to enhance our R&D capabilities, expand our state-of-the-art GMP compliant manufacturing facilities, and increase our capacity for highly potent drug development. Our latest expansion, due to launch in Q3 of 2025, reinforces our commitment to advanced pharmaceutical manufacturing, regulatory compliance (FDA, EMA, HPRA), and supply chain excellence. 

Today, Eirgen Pharma is led by Damien Burke. Eirgen now serves patients in more than 60 countries worldwide including major pharmaceutical markets in the USA, Europe, Japan, Canada, the Middle East, Australia, and Africa. 

 

Our Vision

Improve patient lives

Core
Values

Trust

At Eirgen, we don’t have customers or clients, we have partners. And partnerships are built on trust. By consistently delivering the highest standards of quality, professionalism, and integrity, our goal is to become the only partner your company will ever need. The CDMO that you can genuinely trust.

Growth

Our dedication to continuous improvement and innovation has allowed us to grow as a company and continuously learn from our experiences. The knowledge we gain enables us to consistently enhance our processes and ensure that our partners and their patients receive only the highest quality products.

Care

We care about our people, our community and the environment. We are particularly passionate about providing support and opportunities for the Eirgen team. This has seen us develop a people-centric, high performance culture where everyone can work, learn, enjoy, and excel as one.

lab 3.00_00_53_02.Still005.png

PARTNER WITH US 
Need assistance with a project?  Hit the button below and make contact our BD Team

Eirgen Pharma virtual tour.
Take a glimpse into our world. 

Interested in partnering with Eirgen Pharma?
Contact our Business Development Team

Discover More

Discover Eirgen Pharma, a globally leading CDMO, CPO, and CMO specializing in high-potency pharmaceutical development and manufacturing.

bottom of page